Abstract:Ogden syndrome, also known as NAA10‐related neurodevelopmental syndrome, is a rare genetic condition associated with pathogenic variants in the NAA10 N‐terminal acetylation family of proteins. The condition was initially described in 2011 and is characterized by a range of neurologic symptoms, including intellectual disability and seizures, as well as developmental delays, psychiatric symptoms, congenital heart abnormalities, hypotonia, and others. Previously published articles have described the etiology and phenotype of Ogden syndrome, mostly with retrospective analyses; herein, we report prospective data concerning its progress over time. The current study involves a total of 58 distinct participants; of these, 43 caregivers were interviewed using the Vineland‐3 and answered a survey regarding therapy and other questions, 10 of whom completed the Vineland‐3 but did not answer the survey, and 5 participants who answered the survey but have not yet performed the Vineland‐3 due to language constraints. The average age at the time of the most recent assessment was 12.4 years, with individuals ranging in age from 11 months to 40.2 years. Using Vineland‐3 scores, we show decline in cognitive function over time in individuals with Ogden syndrome (n = 53). Sub‐domain analysis found the decline to be present across all modalities. In addition, we describe the nature of seizures in this condition in greater detail, as well as investigate how already‐available non‐pharmaceutical therapies impact individuals with NAA10‐related neurodevelopmental syndrome. Additional investigation between seizure and non‐seizure groups showed no significant difference in adaptive behavior outcomes. A therapy investigation showed speech therapy to be the most commonly used therapy by individuals with NAA10‐related neurodevelopmental syndrome, followed by occupational and physical therapy, with more severely affected individuals receiving more types of therapy than their less‐severe counterparts. Early intervention analysis was only significantly effective for speech therapy, with analyses of all other therapies being non‐significant. Our study portrays the decline in cognitive function over time of individuals within our cohort, independent of seizure status, and therapies being received, and highlights the urgent need for the development of effective treatments for Ogden syndrome.

NAA10 gene related Ogden syndrome with obstructive hypertrophic cardiomyopathy: A rare case report

Clinical Manifestations in a Chinese Girl with Heterozygous De Novo NAA10 Variant C. 247C > T, P. (arg83cys): a Case Report

Mutation Analysis of AAAS Gene in a Child with Allgrove Syndrome

A Novel OPA1 Mutation in a Chinese Family with Autosomal Dominant Optic Atrophy

NAA10 mutation causing a novel intellectual disability syndrome with Long QT due to N-terminal acetyltransferase impairment

A repository of Ogden syndrome (NAA10) and NAA15 patient derived iPSC lines and isogenic pairs by X-chromosome screening and genome-editing.

Novel Mutations in DAX1 of X-linked Adrenal Hypoplasia Congenita over Several Generations in One Family.

A four-year-old girl with pathogenic variant in the NAA10 gene and precocious puberty - case report and literature review

A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism.

Abstract P1037: Dysfunction Of N-terminal Acetylation Causes Multiple Electrical Abnormalities Leading To Long QT Syndrome And Dilated Cardiomyopathy

Contiguous gene syndrome involving DAX 1 and IL 1 RAPL resulting in adrenal hypoplasia congenita with mental retardation in male child : a case report

Longitudinal adaptive behavioral outcomes in Ogden syndrome by seizure status and therapeutic intervention

Different AHO Phenotype in a Chinese Family with a Novel GNAS Missense Variant: a Case Report.

Naa10 regulates hippocampal neurite outgrowth via Btbd3 N-α-acetylation-mediated actin dynamics

A Natural History of NAA15-related Neurodevelopmental Disorder Through Adolescence

The first case report of CODAS syndrome in Chinese population caused by two LONP1 pathogenic mutations

Case report: Clinical and genetic analysis of a family with nonsyndromic auditory neuropathy

Dose Dependence Effect in Biallelic <i>WNT10A</i> Variant-Associated Tooth Agenesis Phenotype

Helsmoortel–van der Aa syndrome in a Chinese pediatric patient due to ADNP nonsense mutation: A case report

Molecular genetic analysis of two novel a allele to cause Ax phenotype in Chinese

Non-coding CGG Repeat Expansion in LOC642361/NUTM2B-AS1 is Associated with a Phenotype of Oculopharyngodistal Myopathy.